2) lung cancer with hydrothorax
肺癌并胸腔积液
3) lung cancer accompanied with hydrothorax
肺癌伴胸腔积液
4) lung cancer with pleural fluid
肺癌合并胸腔积液
1.
Objective It is to investigate the diagnostic value of the combined detection of CEA,Cyfra211,α1-AGP,CA125 for lung cancer with pleural fluid.
目的探讨血清和胸水CEA、Cyfra211、α1-AGP、CA125联合检测对肺癌合并胸腔积液的诊断价值。
5) Malignant pleural effusion
癌性胸腔积液
1.
Treatment of malignant pleural effusion using S_(311) anticancer vaccine by intrapleural injection;
S_(311)抗癌菌苗治疗癌性胸腔积液的临床研究
6) malignant pleural effusion and ascites
癌性胸/腹腔积液
1.
Methods: 125 Ser-rhIL-2 was administered subcutaneuously or intracavitarily in patients with advanced renal cell carcinoma, malignant melanoma or malignant pleural effusion and ascites.
其中癌性胸/腹腔积液和实体瘤患者分别为 141和 31例 ,有效率分别为 80 。
补充资料：癌性胸腔积液
癌性胸腔积液
malignant pleural effusion
指因胸膜、纵隔、肺原发或转移性肿瘤，致胸膜渗出增多，淋巴与静脉回流障碍引起的胸膜腔积液。多具有血性、低度渗出性，积液量大和渗出迅速等特点。治疗可穿刺抽液，闭式引流，胸内注射抗癌药或四环素封闭胸膜腔。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条